Amir Kaisary

1.0k total citations
24 papers, 804 citations indexed

About

Amir Kaisary is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amir Kaisary has authored 24 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amir Kaisary's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Hormonal and reproductive studies (5 papers). Amir Kaisary is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Hormonal and reproductive studies (5 papers). Amir Kaisary collaborates with scholars based in United Kingdom, United States and Austria. Amir Kaisary's co-authors include CJ Tyrrell, W.B. Peeling, K. Griffiths, Peter Iversen, Teuvo L.J. Tammela, Angela C Webster, John Anderson, L. Baert, M. C. Chamberlain and G. Blackledge and has published in prestigious journals such as Clinical Cancer Research, European Urology and Urology.

In The Last Decade

Amir Kaisary

24 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Kaisary United Kingdom 12 544 252 144 133 104 24 804
Ivy L. Fowler United States 7 591 1.1× 212 0.8× 86 0.6× 127 1.0× 134 1.3× 14 880
Raoul S. Concepcion United States 18 739 1.4× 154 0.6× 215 1.5× 165 1.2× 253 2.4× 57 1.1k
Thomas Spires United States 12 268 0.5× 78 0.3× 182 1.3× 170 1.3× 47 0.5× 15 790
K. Gary Barnette United States 12 325 0.6× 187 0.7× 319 2.2× 194 1.5× 63 0.6× 31 810
Shinji Kageyama Japan 14 295 0.5× 351 1.4× 177 1.2× 226 1.7× 170 1.6× 41 912
Paul Toren Canada 19 681 1.3× 219 0.9× 228 1.6× 425 3.2× 272 2.6× 77 1.2k
Glenn Tisman United States 16 166 0.3× 89 0.4× 179 1.2× 168 1.3× 48 0.5× 33 788
Seiichi Hayato Japan 13 212 0.4× 116 0.5× 259 1.8× 125 0.9× 128 1.2× 26 855
Mark C. Scholz United States 12 469 0.9× 181 0.7× 203 1.4× 86 0.6× 91 0.9× 36 740
Jeff M. Holzbeierlein United States 6 364 0.7× 120 0.5× 89 0.6× 319 2.4× 153 1.5× 7 963

Countries citing papers authored by Amir Kaisary

Since Specialization
Citations

This map shows the geographic impact of Amir Kaisary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Kaisary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Kaisary more than expected).

Fields of papers citing papers by Amir Kaisary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Kaisary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Kaisary. The network helps show where Amir Kaisary may publish in the future.

Co-authorship network of co-authors of Amir Kaisary

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Kaisary. A scholar is included among the top collaborators of Amir Kaisary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Kaisary. Amir Kaisary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Sharyn, Liquan Gao, Roberto Dina, et al.. (2009). IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer. Clinical Cancer Research. 15(4). 1145–1154. 17 indexed citations
2.
Djavan, Bob, V. Ravery, Bernardo Rocco, et al.. (2007). European Study of Radical Prostatectomy: time trends in Europe, 1993–2005. British Journal of Urology. 100(s2). 22–25. 14 indexed citations
3.
Djavan, Bob, Bernardo Rocco, V. Ravery, et al.. (2006). EUROPEAN STUDY ON RADICAL PROSTATECTOMY (ESRPE)-PART I: SURGICAL AND ONCOLOGICAL RESULTS AND CHANGES 1993-2004. European Urology Supplements. 5(2). 129–129. 1 indexed citations
4.
Khan, Fiqe, Amir Kaisary, G. Boustead, David Gillatt, & Mathias Winkler. (2005). PSA recurrence following radical prostatectomy is comparable for all age groups in the UK. Prostate Cancer and Prostatic Diseases. 8(2). 158–162. 6 indexed citations
5.
Anagnostou, Theodore, Yan Kit Fong, Mesut Remzi, et al.. (2005). What's New in Prostate Cancer, Benign Prostatic Hyperplasia, and Minimally Invasive Surgery?: Highlights from the XIXth Congress of the European Association of Urology, March 23-27, 2004, Vienna, Austria.. PubMed. 7(1). 18–40. 1 indexed citations
6.
Winkler, Mathias, Fiqe Khan, A.A. Okeke, et al.. (2004). Case Selection for Radical Prostatectomy in the UK. European Urology. 46(4). 444–450. 1 indexed citations
7.
Kaisary, Amir & Michael Jarmulowicz. (2003). Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)—Agonist Therapy in Prostate Cancer. 3(2). 51–62. 1 indexed citations
8.
9.
Iversen, Peter, et al.. (2000). The effect on sexual interest of `Casodex' (bicalutamide). 150 mg compared with castration in patients with advanced prostate cancer. 86. 220–220. 32 indexed citations
10.
Blake, Glen M., et al.. (2000). 'Casodex' may preserve bone mineral density of patients with advanced prostate cancer. 86. 220–221. 4 indexed citations
11.
12.
Kaisary, Amir, et al.. (1997). Localised carcinoma of the prostate: a paradigm of uncertainty. Postgraduate Medical Journal. 73(865). 691–696. 3 indexed citations
13.
Kaisary, Amir, Peter Klarskov, & David McKillop. (1996). Absence of hepatic enzyme induction in prostate cancer patients receiving `Casodex' (bicalutamide). Anti-Cancer Drugs. 7(1). 54–59. 10 indexed citations
14.
Kaisary, Amir, et al.. (1995). A Randomised Comparison ofMonotherapy with Casodex 50 mgDaily and Castration in theTreatment of Metastatic ProstateCarcinoma. European Urology. 28(3). 215–222. 33 indexed citations
15.
Kaisary, Amir, Patrick J. Smith, Adedayo Adedoyin, et al.. (1994). Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. Pharmacogenetics. 4(4). 199–207. 15 indexed citations
16.
Kaisary, Amir. (1994). Current clinical studies with a new nonsteroidal antiandrogen, casodex. The Prostate. 25(S1). 27–33. 38 indexed citations
17.
Kaisary, Amir, et al.. (1992). The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer. Pharmacogenetics. 2(3). 128–134. 15 indexed citations
18.
Kaisary, Amir, CJ Tyrrell, W.B. Peeling, & K. Griffiths. (1991). Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic Carcinoma. British Journal of Urology. 67(5). 502–508. 150 indexed citations
19.
Ferro, M., et al.. (1989). Testing the Chemosensitivity of Renal Carcinoma in vitro. British Journal of Urology. 64(1). 25–29. 1 indexed citations
20.
Kaisary, Amir, et al.. (1987). Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.. PubMed. 47(20). 5488–93. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivy L. Fowler Breakdown of academic impact, for papers by Raoul S. Concepcion Breakdown of academic impact, for papers by Thomas Spires Breakdown of academic impact, for papers by K. Gary Barnette Breakdown of academic impact, for papers by Shinji Kageyama Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Glenn Tisman Breakdown of academic impact, for papers by Seiichi Hayato Breakdown of academic impact, for papers by Mark C. Scholz Breakdown of academic impact, for papers by Jeff M. Holzbeierlein
Rankless by CCL
2026